Jessica Hagen’s Post

In an exclusive series by MobiHealthNews, we explore the evolving digital health investment landscape from various stakeholders’ perspectives. In the first installment of this eight-part series, Daisy Wolf, investing partner at Andreessen Horowitz (a16z Bio + Health), shares her expert perspective, highlighting the sector's potential and offering strategic advice for founders. Click the link below to check out part one of the investment series and stay tuned for part two coming out on Thursday! #DigitalHealth #HealthcareInnovation #AIinHealthcare #HealthTech #InvestmentStrategy #digitalhealthinvestment #MobiHealthNews #AndreessenHorowitz HIMSS HIMSS Media

We need more funding and research for better health for all women. Investing in women’s health is investing in the mothers of today and tomorrow’s generations.

Report: Digital health investment is rebounding in 2024

State of digital health investment, part 4: Atropos Health - MobiHealthNews #Introduction Atropos Health is a digital health company focused on improving patient outcomes through innovative technology solutions. #Company Background Atropos Health was founded by a team of healthcare and technology experts with a passion for transforming the industry. #Key Offerings Their key offerings include a patient engagement platform, remote monitoring solutions, and data analytics tools for healthcare providers. #Funding and Investments Atropos Health recently secured a significant amount of funding to further develop their products and expand their reach in the market. #Future Outlook The future looks bright for Atropos Health as they continue to innovate and grow in the digital health space. #Conclusion Atropos Health is poised to make a significant impact in the healthcare industry with ai.mediformatica.com #health #funding #market #healthcare #atropos #investment #investors #technology #well #brighamhyde #change #atroposhealth #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/4dqLqen)

The #digitalhealth space has seen some exciting advancements over the past few years, but it seems to be experiencing a reset as investment drops off. Here is a look into some current digital health #investment trends and what investors are looking for moving forward. #healthcare

We are thrilled to announce our partnership with the newly established Women's Health Access Matters (WHAM) Investment Collaborative. 🎉 This initiative aims to boost funding for women-founded startups, enhance awareness and due diligence processes to accelerate the lab-to-market pipeline, and provide comprehensive industry insights through a consortium of esteemed leaders dedicated to increased investment in women’s health #research and #innovation. We are proud to invest in this crucial initiative alongside other venture capitalists, bringing a unique perspective and insight from UPMC's academic and clinical experts, as well as our community partners. The world-renowned expertise of our colleagues at UPMC Magee-Womens Hospital and Magee-Womens Research Institute & Foundation will be invaluable in driving improved health outcomes and economic returns for women’s health. Anna Mamo, MS, MBA, director of Translational Sciences, UPMC Enterprises, is a founding member of the Collaborative, bringing her extensive expertise in both science and business to transform the investment landscape for women’s health care. Together, we are paving the way for groundbreaking innovations in #WomensHealth. https://lnkd.in/dMMfAXfW

UPMC Enterprises joined the newly launched Women's Health Access Matters (WHAM) Investment Collaborative, with Anna Mamo, MS, MBA of Translational Sciences at UPMC Enterprises, serving as a founding member. Learn more about the partnership and how the consortium plans to target women’s health innovations ➡️ https://lnkd.in/g3XXv3JQ

Unlocking the Truth: "Bad Blood" in Health Tech Investment🩸 Curious about the biases and pitfalls shaping the health tech investment scene? Dive into our latest article, where we unravel the Theranos saga and explore the broader landscape of start-ups promising revolution without solid proof. Discover how biases influence investment decisions, hindering diverse and impactful innovations. Our deep dive into the ROI of digital health investments reveals a grim reality: lots of cash, minimal returns. But there's hope. At Adapt, we're not riding the hype train; we're navigating the path to meaningful innovation. We bridge the gap between starry-eyed investment and impactful solutions that enhance care and deliver real ROI. Join us in reshaping the future of health tech investment. Check out the article here: https://lnkd.in/e62sb59q #healthtech #investment #biasintech

“Women’s health might finally be getting the attention it deserves, according to an analysis of US health tech investment trends.” Ummm… followup: “While women’s health represents an opportunity for innovation in a critical market, companies in this space attract just 2% of the venture funding allocated for the entire health care industry, according to our analysis of PitchBook data.” Investment grew 5% and now its 2%? Investment fell 27% so +5% is like 32%? Or is it 2%? Let me make it simple: It’s not enough. https://lnkd.in/gRRB_YSt

"There is nothing more important than actualizing innovation and scientific breakthroughs for women, to ensure Generational Health." Sanskriti Thakur, TOWER CAPITAL GROUP Founder and Chairwoman #femtech #womenshealth #womenshealthinnovation #femhealth #ecosystem #investment #healthcare #healthcareinnovation #generationalhealth #health #partnership #investor #venturecapital